Verrica Pharmaceuticals Competitors and Similar CompaniesClear all
Verrica Pharmaceuticals's competitors and similar companies include Aravive, Alexion Pharmaceuticals, Ansun BioPharma and ITeos Therapeutics.
 Verrica Pharmaceuticals Verrica Pharmaceuticals is developing proprietary topical therapies for the treatment of lesional skin diseases such as Verruca vulgaris (common warts and plantar warts) and Molluscum contagiosum. |  Aravive Aravive is a clinical-stage biotechnology company developing therapies for solid tumors and hematologic malignancies. |  Alexion Pharmaceuticals Alexion (also known as Alexion, AstraZeneca Rare Disease) is a biopharmaceutical company engaged in therapies for rare diseases. |  Ansun BioPharma Ansun BioPharma is a biopharmaceutical company focused on the development of host-directed anti-viral therapies for respiratory viruses. |  ITeos Therapeutics ITeos Therapeutics is a pharmaceutical company that develops immunotherapy solutions. | |
Founding Date | Founding Date 2013 | Founding Date 2008 | Founding Date 1992 | Founding Date 2003 | Founding Date 2011 |
Type | Type Public | Type Public | Type Public | Type Private | Type Public |
Tags | |||||
Locations | Locations West Chester, US HQ | Locations Houston, US HQ | Locations Boston, US HQ Frenchs Forest, AU Wien, AT Elsene, BE São Paulo, BR Vaughan, CA Shanghai, CN see more | Locations San Diego, US HQ | Locations Watertown, US HQ Charleroi, BE |
Employees | Employees 176% increase | Employees 23 | Employees 10,6006% increase | Employees 22 | Employees 17310% increase |
Valuation ($) | Valuation ($) 71.7 m | Valuation ($) 2.9 m | Valuation ($) 40.3 b | Valuation ($) N/A | Valuation ($) 313.4 m |
Financial | |||||
Revenue (est.) | Revenue (est.) $35.6m (FY, 2025) | Revenue (est.) $9.1m (FY, 2022) | Revenue (est.) $6.1b (FY, 2020) | Revenue (est.) N/A | Revenue (est.) $35m (FY, 2024) |
Net income | Net income ($17.9m) (FY, 2025) | Net income ($76.3m) (FY, 2022) | Net income $603.4m (FY, 2020) | Net income N/A | Net income ($134.4m) (FY, 2024) |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 183.9m | Total funding raised $ 215m |
For sources of this data, please see the company profile
View Company Profiles
Aravive
HQ
Houston, US
Employees
23
Aravive is a clinical-stage biotechnology company developing therapies for solid tumors and hematologic malignancies.
View companyAlexion Pharmaceuticals
HQ
Boston, US
Employees
10,600↑ 6% increase
Alexion (also known as Alexion, AstraZeneca Rare Disease) is a biopharmaceutical company engaged in therapies for rare diseases.
View companyAnsun BioPharma
HQ
San Diego, US
Employees
22
Ansun BioPharma is a biopharmaceutical company focused on the development of host-directed anti-viral therapies for respiratory viruses.
View companyITeos Therapeutics
HQ
Watertown, US
Employees
173↑ 10% increase
ITeos Therapeutics is a pharmaceutical company that develops immunotherapy solutions.
View company